Bell Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bell Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.61K	Sell	136 -4	-3%	-$133	﹤0.01%	1013
2026 Q1	$4.22K	Sell	140 -116	-45%	-$3.73K	﹤0.01%	1035
2025 Q4	$7.99K	Buy	256 +150	+142%	+$3.69K	﹤0.01%	781
2025 Q3	$2.14K	Sell	106 -50	-32%	-$878	﹤0.01%	1309
2025 Q2	$2.62K	Hold	156	–	–	﹤0.01%	1259
2025 Q1	$2.4K	Hold	156	–	–	﹤0.01%	1240
2024 Q4	$3.44K	Hold	156	–	–	﹤0.01%	1112
2024 Q3	$2.81K	Hold	156	–	–	﹤0.01%	1213
2024 Q2	$2.54K	Sell	156 -38	-20%	-$585	﹤0.01%	1256
2024 Q1	$2.74K	Buy	194 +37	+24%	+$466	﹤0.01%	1213
2023 Q4	$1.64K	Buy	157 +25	+19%	+$233	﹤0.01%	1417
2023 Q3	$1.35K	Buy	+132	New	+$1.23K	﹤0.01%	1458

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bell Investment Advisors's TEVA Position: Q2 2026 in Review

Bell Investment Advisors reduced its Teva Pharmaceuticals (TEVA) stake by 2.9% in Q2 2026, selling an estimated $133 and leaving 136 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1013.

Bell Investment Advisors first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.99K in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Bell Investment Advisors held 136 shares of Teva Pharmaceuticals worth $4.61K as of Q2 2026.
Bell Investment Advisors sold 4 Teva Pharmaceuticals shares in Q2 2026, an estimated $133.
Teva Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1013 holding.
Bell Investment Advisors first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
Bell Investment Advisors's Teva Pharmaceuticals position peaked at $7.99K in Q4 2025.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.